Supercharged immune cells take on nasopharyngeal cancer
NCT ID NCT02065362
First seen Jan 31, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This early-stage study tests a new immune cell therapy for people with a type of throat cancer linked to the Epstein-Barr virus. Researchers take the patient's own T cells, train them to recognize the virus on cancer cells, and add a gene to make them resist a chemical that tumors use to hide. The goal is to see if these enhanced cells are safe and can survive in the body to fight the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EBV-POSITIVE NASOPHARYNGEAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Texas Children's Hospital
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.